Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Complete Genomics provides commercial DNA sequencing platforms and services for whole human genome analysis. Their technologies have been used in research on genetic diseases, oncology, neurology, rare disease discovery, and population genomics. The company does not develop therapeutics or diagnostics directly but enables such work through its platforms. Recent advances include the launch of new sequencers and stLFR technology for improved phasing and structural variant detection. No clinical trial results are reported as it does not run drug/device trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Complete Genomics.